NUR-641E Advanced Pathophysiology &
Pharmacology – 2026/2027 Academic Year –
Comprehensive Midterm Practice Question
Bank with Rationales and Distractor Analysis |
with complete solutions.
SECTION 1: PHARMACOKINETICS AND
PHARMACODYNAMICS (Questions 1-5)
1. A patient with cirrhosis is prescribed a medication that undergoes
extensive first-pass metabolism. What pharmacokinetic change is
most expected?
A) Lower absorption
B) Higher bioavailability
C) Faster excretion
D) Reduced distribution
Answer: B) Higher bioavailability
Rationale: Hepatic impairment reduces first-pass metabolism, allowing more
of the drug to enter systemic circulation unchanged, thereby increasing its
bioavailability . First-pass metabolism occurs in the liver, where drugs are
metabolized before reaching systemic circulation. When liver function is
compromised, a larger proportion of the drug reaches the target tissues.
Distractor Analysis:
, A) Lower absorption: Absorption is not directly affected by liver
disease.
C) Faster excretion: Excretion is typically impaired in cirrhosis.
D) Reduced distribution: Distribution can be altered due to
decreased protein synthesis, but bioavailability is the primary change
related to first-pass metabolism.
Source: NUR 641E Final Exam Study Guide, Docsity
2. A nurse educator is explaining the concept of a prodrug. Which
statement accurately describes a prodrug?
A) It is the active form of a medication immediately upon administration.
B) It is a biologically inactive compound that is metabolized in the body to
produce the active drug.
C) It is a drug that is only effective when administered intravenously.
D) It is a medication that bypasses the hepatic first-pass effect.
Answer: B) It is a biologically inactive compound that is metabolized
in the body to produce the active drug.
Rationale: A prodrug is a pharmacologically inactive compound that is
metabolized in the body to produce an active drug . Prodrugs are designed
to improve bioavailability, reduce side effects, or target specific tissues.
Examples include codeine (metabolized to morphine) and clopidogrel
(metabolized to its active form).
Distractor Analysis:
A) It is the active form of a medication immediately upon
administration: This describes an active drug, not a prodrug.
C) It is a drug that is only effective when administered
intravenously: This is not related to the definition of a prodrug.
D) It is a medication that bypasses the hepatic first-pass
effect: While some prodrugs are designed to do this, it is not the
defining characteristic of a prodrug.
Source: NUR 641E Final Exam Study Guide, Docsity
,3. A patient receives a drug with a half-life of 8 hours.
Approximately how long will it take to reach a steady-state
concentration?
A) 8 hours
B) 16 hours
C) 40 hours
D) 80 hours
Answer: C) 40 hours
Rationale: Most drugs reach a steady state after approximately 4-5 half-lives
. Four to five half-lives of an 8-hour drug is 32-40 hours. Steady state is
achieved when the rate of drug administration equals the rate of drug
elimination, resulting in relatively constant plasma concentrations.
Distractor Analysis:
A) 8 hours: This is only one half-life.
B) 16 hours: This is two half-lives.
D) 80 hours: This is ten half-lives, which is longer than necessary to
reach steady state.
Source: NUR 641E Final Exam Study Guide, Docsity
4. The cytochrome P450 system is primarily responsible for which
pharmacokinetic process?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
, Answer: C) Metabolism
Rationale: The cytochrome P450 system is a superfamily of enzymes,
primarily found in the liver, that plays a crucial role in metabolizing drugs,
chemicals, and endogenous substances, converting them into more water-
soluble forms for excretion . CYP3A4 is the most abundant CYP enzyme and
is responsible for metabolizing approximately 50% of all drugs. Drug
interactions often occur through CYP enzyme inhibition or induction.
Distractor Analysis:
A) Absorption: The movement of a drug from its administration site
into the bloodstream.
B) Distribution: The movement of a drug from the bloodstream into
the interstitial and intracellular fluid.
D) Excretion: The elimination of a drug and its metabolites from the
body.
Source: NUR 641E Final Exam Study Guide, Docsity
5. A patient taking clopidogrel (Plavix) is prescribed omeprazole for
GERD. What is the primary concern with this combination?
A) Increased risk of bleeding
B) Reduced antiplatelet efficacy of clopidogrel
C) Increased risk of serotonin syndrome
D) Nephrotoxicity
Answer: B) Reduced antiplatelet efficacy of clopidogrel
Rationale: Clopidogrel is a prodrug that requires activation by the hepatic
CYP2C19 enzyme . Omeprazole is a potent inhibitor of CYP2C19 and can
block the conversion of clopidogrel to its active metabolite, reducing its
antiplatelet effect . This interaction can increase the risk of cardiovascular
Pharmacology – 2026/2027 Academic Year –
Comprehensive Midterm Practice Question
Bank with Rationales and Distractor Analysis |
with complete solutions.
SECTION 1: PHARMACOKINETICS AND
PHARMACODYNAMICS (Questions 1-5)
1. A patient with cirrhosis is prescribed a medication that undergoes
extensive first-pass metabolism. What pharmacokinetic change is
most expected?
A) Lower absorption
B) Higher bioavailability
C) Faster excretion
D) Reduced distribution
Answer: B) Higher bioavailability
Rationale: Hepatic impairment reduces first-pass metabolism, allowing more
of the drug to enter systemic circulation unchanged, thereby increasing its
bioavailability . First-pass metabolism occurs in the liver, where drugs are
metabolized before reaching systemic circulation. When liver function is
compromised, a larger proportion of the drug reaches the target tissues.
Distractor Analysis:
, A) Lower absorption: Absorption is not directly affected by liver
disease.
C) Faster excretion: Excretion is typically impaired in cirrhosis.
D) Reduced distribution: Distribution can be altered due to
decreased protein synthesis, but bioavailability is the primary change
related to first-pass metabolism.
Source: NUR 641E Final Exam Study Guide, Docsity
2. A nurse educator is explaining the concept of a prodrug. Which
statement accurately describes a prodrug?
A) It is the active form of a medication immediately upon administration.
B) It is a biologically inactive compound that is metabolized in the body to
produce the active drug.
C) It is a drug that is only effective when administered intravenously.
D) It is a medication that bypasses the hepatic first-pass effect.
Answer: B) It is a biologically inactive compound that is metabolized
in the body to produce the active drug.
Rationale: A prodrug is a pharmacologically inactive compound that is
metabolized in the body to produce an active drug . Prodrugs are designed
to improve bioavailability, reduce side effects, or target specific tissues.
Examples include codeine (metabolized to morphine) and clopidogrel
(metabolized to its active form).
Distractor Analysis:
A) It is the active form of a medication immediately upon
administration: This describes an active drug, not a prodrug.
C) It is a drug that is only effective when administered
intravenously: This is not related to the definition of a prodrug.
D) It is a medication that bypasses the hepatic first-pass
effect: While some prodrugs are designed to do this, it is not the
defining characteristic of a prodrug.
Source: NUR 641E Final Exam Study Guide, Docsity
,3. A patient receives a drug with a half-life of 8 hours.
Approximately how long will it take to reach a steady-state
concentration?
A) 8 hours
B) 16 hours
C) 40 hours
D) 80 hours
Answer: C) 40 hours
Rationale: Most drugs reach a steady state after approximately 4-5 half-lives
. Four to five half-lives of an 8-hour drug is 32-40 hours. Steady state is
achieved when the rate of drug administration equals the rate of drug
elimination, resulting in relatively constant plasma concentrations.
Distractor Analysis:
A) 8 hours: This is only one half-life.
B) 16 hours: This is two half-lives.
D) 80 hours: This is ten half-lives, which is longer than necessary to
reach steady state.
Source: NUR 641E Final Exam Study Guide, Docsity
4. The cytochrome P450 system is primarily responsible for which
pharmacokinetic process?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
, Answer: C) Metabolism
Rationale: The cytochrome P450 system is a superfamily of enzymes,
primarily found in the liver, that plays a crucial role in metabolizing drugs,
chemicals, and endogenous substances, converting them into more water-
soluble forms for excretion . CYP3A4 is the most abundant CYP enzyme and
is responsible for metabolizing approximately 50% of all drugs. Drug
interactions often occur through CYP enzyme inhibition or induction.
Distractor Analysis:
A) Absorption: The movement of a drug from its administration site
into the bloodstream.
B) Distribution: The movement of a drug from the bloodstream into
the interstitial and intracellular fluid.
D) Excretion: The elimination of a drug and its metabolites from the
body.
Source: NUR 641E Final Exam Study Guide, Docsity
5. A patient taking clopidogrel (Plavix) is prescribed omeprazole for
GERD. What is the primary concern with this combination?
A) Increased risk of bleeding
B) Reduced antiplatelet efficacy of clopidogrel
C) Increased risk of serotonin syndrome
D) Nephrotoxicity
Answer: B) Reduced antiplatelet efficacy of clopidogrel
Rationale: Clopidogrel is a prodrug that requires activation by the hepatic
CYP2C19 enzyme . Omeprazole is a potent inhibitor of CYP2C19 and can
block the conversion of clopidogrel to its active metabolite, reducing its
antiplatelet effect . This interaction can increase the risk of cardiovascular
